Adam R. Craig - Dec 31, 2021 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role
President and CEO, Director
Signature
/s/ Bruce J. Seeley, attorney-in-fact for Adam R. Craig
Stock symbol
CTIC
Transactions as of
Dec 31, 2021
Transactions value $
$6,699
Form type
4
Date filed
3/11/2022, 06:39 PM
Previous filing
Dec 2, 2021
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTIC Common Stock Award $6.7K +3.18K +23.54% $2.11* 16.7K Dec 31, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTIC Stock Option (right to buy) Award $0 +1.12M $0.00 1.12M Mar 9, 2022 Common Stock 1.12M $4.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
F2 The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates.